Mutant HBsAg Virus-Like Particle Chimeras as Immunogenic Carriers for Medically Relevant Malaria Epitopes

2017-05-09T04:25:09Z (GMT) by NATALIE JEAN KINGSTON
This research investigated the use of hepatitis B surface antigen (HBsAg) virus-like particles (VLPs) as vaccine platforms for the delivery of foreign antigens in immune systems with prior HBsAg exposure.